Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Perini

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesisTao Liu, Andrew E L Tee, Antonio Porro, et al.
The Journal of Biological Chemistry|March 18, 2010
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cellsAntonio Porro, Michelle Haber, Daniel Diolaiti, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|September 5, 2017
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expressionSamuele Gherardi, Matteo Bovolenta, Chiara Passarelli, et al.
Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
Oncotarget|February 18, 2016
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patientsStefania Trino, Ilaria Iacobucci, Daniela Erriquez, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
Haematologica|August 10, 2012
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapySabrina Angelini, Simona Soverini, Gloria Ravegnini, et al.
Nature Communications|June 29, 2021
Restoration of the molecular clock is tumor suppressive in neuroblastomaMyrthala Moreno-Smith, Giorgio Milazzo, Ling Tao, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
Journal of the National Cancer Institute|June 8, 2014
Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progressionPei Y Liu, Daniela Erriquez, Glenn M Marshall, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesisTao Liu, Andrew E L Tee, Antonio Porro, et al.
The Journal of Biological Chemistry|March 18, 2010
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cellsAntonio Porro, Michelle Haber, Daniel Diolaiti, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|September 5, 2017
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expressionSamuele Gherardi, Matteo Bovolenta, Chiara Passarelli, et al.
Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
Oncotarget|February 18, 2016
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patientsStefania Trino, Ilaria Iacobucci, Daniela Erriquez, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
Haematologica|August 10, 2012
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapySabrina Angelini, Simona Soverini, Gloria Ravegnini, et al.
Nature Communications|June 29, 2021
Restoration of the molecular clock is tumor suppressive in neuroblastomaMyrthala Moreno-Smith, Giorgio Milazzo, Ling Tao, et al.
Blood|July 25, 2008
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistanceIlaria Iacobucci, Annalisa Lonetti, Francesca Messa, et al.
Journal of the National Cancer Institute|June 8, 2014
Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progressionPei Y Liu, Daniela Erriquez, Glenn M Marshall, et al.
Pageof 8